Gamelin Erick 4
4 · Acrivon Therapeutics, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2024-05-14$8.36/sh−402$3,361→ 17,765 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.